BackOptimizeRx Overview
OptimizeRx Corp

OptimizeRx Target Price

Where could OPRX trade next? Consensus target price: $12.

Get informed when a big investor buys or sells

+ Follow

Share Price

$8.57

Average Target Price

$11.5034.2% upside

2 analysts in the last 4 months

High: $12 | Low: $11

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-08-14UBS$1128.4% upsideOpen
2026-08-13Stifel Nicolaus$1240% upsideOpen
2026-05-13UBS$1016.7% upsideOpen
2026-05-13Lake Street$1128.4% upsideOpen
2026-05-13Stephens$718.3% downsideOpen
2026-05-13Stifel Nicolaus$1463.4% upsideOpen
2026-03-06Stifel NicolausDavid Grossman$1798.4% upsideOpen
2025-10-10UBS$23168.4% upsideOpen
2024-04-04JMP SecuritiesConstantine Davides$1575% upsideOpen

OptimizeRx (OPRX) FAQ

OptimizeRx (OPRX) currently reports a target price of $12. Use the charts on this page to explore OptimizeRx's target price history and peer comparisons.

Analysts' average 12-month price target for OptimizeRx is $12, about 34.2% upside from the current share price of $8.57. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $12, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for OptimizeRx, and consider following OPRX for alerts when major investors trade the stock.

OptimizeRx is classified in the Healthcare sector. On target price, it currently shows $12. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing OPRX with unrelated industries.